Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GALR2 | O43603 | 17/20 | 0.82 |
| ▸ | GALR1 | P47211 | 11/20 | 0.82 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GBA1 | P04062 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10143419 | 0.91 | GALR2 (0.81) | GALR2GALR1MAPK1TAAR1GBA1 | |
| SCHEMBL10144388 | 0.90 | GALR2 (1.00) | GALR2GALR1MAPK1TAAR1MEN1 | |
| SCHEMBL10143793 | 0.89 | GALR2 (1.00) | GALR2GALR1 | |
| SCHEMBL10143587 | 0.88 | GALR2 (0.82) | GALR2GALR1MAPK1TAAR1MEN1 | |
| SCHEMBL10143426 | 0.85 | GALR2 (1.00) | GALR2GALR1 | |
| SCHEMBL10143797 | 0.85 | GALR2 (0.83) | GALR2GALR1 | |
| SCHEMBL10144392 | 0.84 | GALR2 (1.00) | GALR2GALR1MAPK1TAAR1MEN1 | |
| SCHEMBL10143796 | 0.83 | GALR2 (1.00) | GALR2GALR1MAPK1TAAR1MEN1 | |
| SCHEMBL10143412 | 0.81 | GALR2 (0.74) | GALR2GALR1MAPK1TAAR1GBA1 | |
| SCHEMBL10143622 | 0.81 | GALR2 (0.77) | GALR2GALR1MAPK1TAAR1GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012009258-A2 | PEPTIDOMIMETIC GALANIN RECEPTOR MODULATORS | ROBERTS EDWARD (US) | 2012-01-19 | — | — | WO | disclosed |